𝔖 Bobbio Scriptorium
✦   LIBER   ✦

S1031 Increased Risk of Lymphoma Among Inflammatory Bowel Disease Patients Treated with Azathioprine in a Dutch Nationwide Study

✍ Scribed by Christine Vos; Noor Bakkal; Robert C. Minnee; Dirk J. De Jong; Gerard Dijkstra; Pieter Stokkers; Ad A. van Bodegraven; Marie J. Pierik; Christien J. van der Woude; Bas Oldenburg; Daniel Hommes


Book ID
119430636
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
160 KB
Volume
136
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Risk of malignant lymphoma in patients w
✍ A.C.W. Vos; N. Bakkal; R.C. Minnee; M.K. Casparie; D.J. de Jong; G. Dijkstra; P. πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 319 KB πŸ‘ 2 views

Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents are important for maintaining disease control in most patients with inflammatory bowel diseases (IBDs); however, their use has been associated with the development of malignant lymphoma. The purpose